Related Experiment Video
Updated: Aug 17, 2026

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways
Published on: December 9, 2013
The development of sex differences in cardiovascular disease mortality: a historical perspective
1Division of Environmental Health Science, Columbia Unviersity School of Public Health, New York, NY, USA.
Insights
Historically, males did not always have higher cardiovascular disease (CVD) mortality rates than females. This study reveals distinct stages in CVD sex differences, with male excess mortality appearing later in the historical record.
Area of Science:
- Epidemiology
- Public Health
- Cardiovascular Disease Research
Background:
- Cardiovascular disease (CVD) mortality rates are higher in males than females, but the historical origins of this disparity are unclear.
- Understanding the historical context of sex differences in CVD mortality is crucial for identifying underlying causes.
Purpose of the Study:
- To investigate historical trends in cardiovascular disease (CVD) mortality differences between males and females.
- To determine if male excess CVD mortality has consistently existed throughout the historical record.
Main Methods:
- Analysis of mortality statistics for cardiovascular disease (CVD) in England and Wales (1861-1992) and the United States (1900-1991).
- Examination of CVD mortality trends across the full range of age groups over time.
Main Results:
- Three distinct stages were identified in the relationship between male and female CVD mortality.
- These stages include an initial period of equal mortality, followed by the emergence of sex differences, and finally, consistent male excess mortality.
- Male excess mortality from CVD is a relatively recent phenomenon in the historical data.
Conclusions:
- Male excess mortality from cardiovascular disease (CVD) is not a constant historical feature.
- Further research is necessary to understand the factors contributing to the current male excess CVD mortality.
Objectives:
Little is known about why males have higher cardiovascular disease (CVD) mortality rates than do females. An important factor that has hampered efforts in this regard is the lack of clarity about whether male excess mortality from CVD has existed throughout history. To answer this question, an investigation was conducted of trends in CVD mortality differences between the sexes from the time when data first became available until the present, including the full range of age groups.
Methods:
Mortality statistics for CVD in England and Wales from 1861 through 1992 and in the United States from 1900 through 1991 were used.
Results:
Three stages in the relationship between male and female CVD mortality were found: (1) An early stage of equal male and female mortality, (2) a stage of the appearance of sex differences in mortality, and (3) a stage with consistently present male excess mortality.
Conclusion:
Male excess mortality from CVD has not always been present in the historical record. Further research is needed to elucidate the causes of this excess mortality.
More Related Videos
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
06:04Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...